Skip to content
December 02, 2024

Investment information for the new generation

Search

FTZ.V

Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the company, as its stock steadily…